{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:19:03Z","timestamp":1773148743979,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.contraception.2008.12.007","type":"journal-article","created":{"date-parts":[[2009,2,8]],"date-time":"2009-02-08T04:10:48Z","timestamp":1234066248000},"page":"428-432","source":"Crossref","is-referenced-by-count":11,"title":["Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada"],"prefix":"10.1016","volume":"79","author":[{"given":"Jan S.","family":"Endrikat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola P.","family":"Milchev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Kapamadzija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jadranka","family":"Georgievska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Gerlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sleem","family":"Feroze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2008.12.007_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13625180008500375","article-title":"Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone","volume":"5","author":"Huber","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2008.12.007_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","article-title":"An open-label, multi-centered study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen","volume":"61","author":"Parsey","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.12.007_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on Oral Contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.12.007_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0010-7824(94)00015-O","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models","volume":"51","author":"Muhn","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.12.007_bib5","first-page":"13","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. A major breakthrough in tomorrow's oral contraception","volume":"3","author":"Foidart","year":"1995","journal-title":"Gynecol Snapshot"},{"key":"10.1016\/j.contraception.2008.12.007_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.12.007_bib7","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1210\/jc.80.6.1816","article-title":"Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin\u2013aldosterone system, body weight, blood pressure, glucose tolerance and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2008.12.007_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/09513590009167683","article-title":"Effect of an oral contraceptive containing drospirenone on the renin\u2013aldosterone system in healthy female volunteers","volume":"14","author":"Oelkers","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2008.12.007_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.contraception.2008.02.007","article-title":"Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives","volume":"77","author":"Hampton","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.12.007_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/13625180008500387","article-title":"A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel","volume":"5","author":"Foidart","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2008.12.007_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.AOG.0000298338.58511.d1","article-title":"Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial","volume":"111","author":"Creinin","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2008.12.007_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0010-7824(99)00097-9","article-title":"Comparison of efficacy, cycle control and tolerability of two low-dose oral contraceptives containing 20 \u03bcg ethinylestradiol\/75 \u03bcg gestodene and 20 \u03bcg ethinylestradiol\/150 \u03bcg desogestrel in a multicenter clinical study","volume":"60","author":"Endrikat","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.12.007_bib13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/00006842-196811000-00006","article-title":"The development of a menstrual distress questionnaire","volume":"30","author":"Moos","year":"1968","journal-title":"Psychosom Med"},{"key":"10.1016\/j.contraception.2008.12.007_bib14","doi-asserted-by":"crossref","unstructured":"Moos R.H. Menstrual distress questionnaire manual. Western Psychological Services, Los Angeles, CA; 1968.","DOI":"10.1037\/t07788-000"},{"key":"10.1016\/j.contraception.2008.12.007_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/13625180701440818","article-title":"A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 mcg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight","volume":"12","author":"Endrikat","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2008.12.007_bib16","first-page":"14","article-title":"A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms","volume":"47","author":"Brown","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2008.12.007_bib17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.contraception.2007.05.080","article-title":"Effect of an oral contraceptive containing 30 microg ethinylestradiol plus 3 mg drospirenone on body composition of young women affected by premenstrual syndrome with symptoms of water retention","volume":"76","author":"Fruzzetti","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.12.007_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.contraception.2006.10.011","article-title":"The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study","volume":"75","author":"Fruzzetti","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.12.007_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/713604397","article-title":"Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms","volume":"8","author":"Apter","year":"2003","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2008.12.007_bib20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.contraception.2005.10.016","article-title":"Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception","volume":"74","author":"Borges","year":"2006","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408005763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408005763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T18:06:40Z","timestamp":1558116400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782408005763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0010782408005763"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2008.12.007","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1161626.623188","asserted-by":"object"}]},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}